EMBLEM, founded in 1999, is the wholly owned subsidiary and exclusive technology and knowledge transfer partner of the European Molecular Biology Laboratory (EMBL). We currently manage a portfolio in excess of 1000 inventions, over 450 patent applications and granted patents, and more than 400 active license contracts with major players in the pharmaceutical, biotech and instrumentation markets.